EX-4.1
from 8-K
5 pages
Second Supplemental Indenture by and Among Protalix Biotherapeutics, Inc., as Issuer, and Each of the Guarantors Party Hereto, and the Bank of New York Mellon Trust Company, N.A., as Trustee, Dated as of November 27, 2017 to the Indenture, Dated as of December 7, 2016, as Supplemented by the First Supplemental Indenture, Dated as of July 24, 2017 Relating to 7.50% Senior Secured Convertible Notes Due 2021 Second Supplemental Indenture
12/34/56
EX-4.2
from 8-K
6 pages
First Supplemental Indenture Between Protalix Biotherapeutics, Inc., as Issuer, and Each of the Guarantors Party Hereto, and the Bank of New York Mellon Trust Company, N.A., as Trustee, and Wilmington Savings Fund Society, Fsb, as Collateral Agent Dated as of July 24, 2017 to the Indenture, Dated as of December 7, 2016, Relating to 7.50% Senior Secured Convertible Notes Due 2021 First Supplemental Indenture
12/34/56